ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 39,050
-150 (-0.38%)
Nov 2, 2026, 11:28 AM KST
ABL Bio Market Cap
ABL Bio has a market cap or net worth of 2.19 trillion as of October 30, 2026. It is the 7,403rd most valuable company in the world and the 172nd biggest in South Korea. Its market cap has decreased by 60.22% in one year.
Market Cap
2.19T
Enterprise Value
2.08T
Revenue
34.28B
Global Rank
Country Rank
#172 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 2.19T, an increase of 259.23%. That is a compound annual growth rate of 17.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 2.19T | -80.17% |
| Dec 30, 2025 | 11.03T | 663.70% |
| Dec 30, 2024 | 1.44T | 22.53% |
| Dec 28, 2023 | 1.18T | 7.19% |
| Dec 29, 2022 | 1.10T | 5.54% |
| Dec 30, 2021 | 1.04T | -27.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 6.08T |
| HLB Co., Ltd. | 5.32T |
| SK bioscience | 2.56T |
| LigaChem Biosciences | 2.27T |
| Peptron | 2.15T |
| OliX Pharmaceuticals | 2.14T |
| Hugel | 1.94T |
| Voronoi | 1.92T |